Glenmede Trust’s Axonics, Inc. Common Stock AXNX Stock Holding History

Glenmede Trust’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,070	Closed	-$386K	–	1377
2023 Q2	$386K	Hold	7,070	–	–	﹤0.01%	910
2023 Q1	$386K	Sell	7,070 -2,580	-27%	-$151K	﹤0.01%	915
2022 Q4	$603K	Sell	9,650 -313	-3%	-$20.8K	﹤0.01%	789
2022 Q3	$701K	Buy	9,963 +2,497	+33%	+$172K	﹤0.01%	737
2022 Q2	$423K	Buy	+7,466	New	+$409K	﹤0.01%	911
2022 Q1	–	Sell	-18,769	Closed	-$1.05M	–	1411
2021 Q4	$1.05M	Buy	+18,769	New	+$1.15M	0.01%	727

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Glenmede Trust's AXNX Position: Q3 2023 in Review

Glenmede Trust sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 7,070 shares — an estimated $386K sold.

Glenmede Trust first reported a position in AXNX in Q4 2021 and held it in 6 quarters. The position peaked at $1.05M in Q4 2021. 220 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

Glenmede Trust reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Glenmede Trust sold 7,070 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $386K.
Glenmede Trust first reported a position in Axonics, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Glenmede Trust's Axonics, Inc. Common Stock position peaked at $1.05M in Q4 2021.
220 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.